After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.
from All Top News -- ScienceDaily https://ift.tt/2QDw8fk
No comments:
Post a Comment